Meghan’s March Madness!
October 2018: PRF Redesigns the Research Grant Program and is Soliciting Grant Proposals Worldwide
Our 2018 Newsletter is Here!
FANTASTIC NEWS! Study Published in JAMA Finds Treatment Extends Survival In a spectacular development, a new study published in The Journal of the American Medical Association (JAMA) shows that treatment with lonafarnib extends lifespan in children with Progeria. This...
On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib
Collaboration marks the first submission for the treatment of Progeria. If approved, children may access drug by prescription instead of clinical trial!! Read our latest press releases here: Progeria Research Foundation Announces Collaboration and Supply Agreement...
English 
Arabic 
Bengali 
Chinese 
Dutch 
French 
German 
Hebrew 
Hindi 
Indonesian 
Italian 
Kannada 
Kazakh 
Korean 
Marathi 
Pashto 
Portuguese 
Russian 
Spanish 
Tamil 
Ukrainian 
Urdu